Apixaban is safer than rivaroxaban in AF: study
Choosing between the two drugs is a choice between thrombotic or haemorrhagic risk
Apixaban is associated with a lower risk of major bleeding and thrombotic events compared with rivaroxaban, a large real-world data analysis shows.